Indivior Pharmaceuticals, Inc.’s Q3 2026 10-Q window runs Oct 27, 2026 to Nov 6, 2026.
Based on 5 prior 10-Q filings.
Indivior Pharmaceuticals, Inc. · CIK 1625297 · Engraved from SEC EDGAR